original_query: What is the focus of Engensis, a biotechnology company established in 1996 in South Korea?
query: What is the focus of Helixmith's Engensis?
answer: Helixmith's Engensis is a non-viral plasmid DNA product designed to express recombinant HGF protein to promote nerve regeneration and blood vessel formation.  It's being developed to treat several conditions including diabetic peripheral neuropathy, diabetic foot ulcers, amyotrophic lateral sclerosis, coronary artery disease, claudication, and Charcot-Marie-Tooth disease.